Literature DB >> 15718160

Timely synthetic support for medicinal chemists.

John Potoski1.   

Abstract

In recent years, there have been significant developments made in the way new drugs are being discovered and developed. Such changes are driven by new technologies that have expanded the opportunities to prepare and screen large libraries of compounds in a rapid time frame by the use of high-throughput synthesis and screening techniques [1-3]. These strategies are driven by the need to shorten time lines for bringing discovery leads to the market [4,5]. As a result, the role and needs of synthetic chemistry in the discovery and development of new therapeutic agents has been altered [6]. This paper will explore the roles of synthetic chemists and how pharmaceutical companies respond to the evolving needs of synthetic chemistry challenges in their discovery and development programs.

Mesh:

Substances:

Year:  2005        PMID: 15718160     DOI: 10.1016/S1359-6446(04)03298-2

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  1 in total

1.  Benzimidazole inhibitors of the protein kinase CHK2: clarification of the binding mode by flexible side chain docking and protein-ligand crystallography.

Authors:  Cornelis Matijssen; M Cris Silva-Santisteban; Isaac M Westwood; Samerene Siddique; Vanessa Choi; Peter Sheldrake; Rob L M van Montfort; Julian Blagg
Journal:  Bioorg Med Chem       Date:  2012-09-21       Impact factor: 3.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.